Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,765 INR | +3.21% | +4.14% | -8.74% |
May. 07 | Gland Pharma Gets US FDA's Approval for Generic ALS Drug | MT |
May. 07 | Gland Pharma Gets US FDA's Approval for Generic Stem Cell Mobilizer Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.74% | 3.37B | |
+30.38% | 684B | |
+29.32% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.35% | 240B | |
+8.74% | 208B | |
-7.81% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- GLAND Stock
- News Gland Pharma Limited
- Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection